Katalog GES



Human Hypoxanthine (Guanine) Phosphoribosyltransferase: An Amino Acid Substitution in a Mutant Form of the Enzyme Isolated from a Patient with Gout

We have investigated the molecular basis for a deficiency of the enzyme hypoxanthine (guanine) phosphoribosyltransferase (HPRT; IMP:pyrophosphate phosphoribosyltransferase, EC 2.4.2.8) in a patient with a severe form of gout. We reported in previous studies the isolation of a unique structural... Full description

1st Person: Wilson, James M.
Additional Persons: Tarr, George E. verfasserin; Kelley, William N. verfasserin
Source: in Proceedings of the National Academy of Sciences of the United States of America Vol. 80, No. 3 (1983), p. 870-873
More Articles
Type of Publication: Article
Language: English
Published: 1983
Keywords: research-article
Medical Sciences
Reverse-Phase HPLC
Peptide Mapping
Mutant Enzyme
Online: Volltext
  Search for full text
LEADER 02241nma a2200325 c 4500
001 JST070116725
003 DE-601
005 20180606000129.0
007 cr uuu---uuuuu
008 150325s1983 000 0 eng d
024 8 |a 13773 
035 |a 13773 
040 |b ger  |c GBVCP 
041 0 |a eng 
100 1 |a Wilson, James M. 
245 1 0 |a Human Hypoxanthine (Guanine) Phosphoribosyltransferase: An Amino Acid Substitution in a Mutant Form of the Enzyme Isolated from a Patient with Gout  |h Elektronische Ressource 
300 |a Online-Ressource 
520 |a We have investigated the molecular basis for a deficiency of the enzyme hypoxanthine (guanine) phosphoribosyltransferase (HPRT; IMP:pyrophosphate phosphoribosyltransferase, EC 2.4.2.8) in a patient with a severe form of gout. We reported in previous studies the isolation of a unique structural variant of HPRT from this patient's erythrocytes and cultured lymphoblasts. This enzyme variant, which is called HPRTLondon, is characterized by a decreased concentration of HPRT protein in erythrocytes and lymphoblasts, a normal Vmax, a 5-fold increased Kmfor hypoxanthine, a normal isoelectric point, and an apparently smaller subunit molecular weight. Comparative peptide mapping experiments revealed a single abnormal tryptic peptide in HPRTLondon. Edman degradation of the aberrant peptide from HPRTLondonidentified a serine-to-leucine amino acid substitution at position 109. This substitution can be explained by a single nucleotide change in the codon for serine-109 (UCA → UUA). Thus a mutation at the HPRT locus has now been defined at the molecular level. 
653 |a research-article 
653 |a Medical Sciences 
653 |a Reverse-Phase HPLC 
653 |a Peptide Mapping 
653 |a Mutant Enzyme 
700 1 |a Tarr, George E.  |e verfasserin  |4 aut 
700 1 |a Kelley, William N.  |e verfasserin  |4 aut 
773 0 8 |i in  |t Proceedings of the National Academy of Sciences of the United States of America  |d Washington, DC : National Acad. of Sciences  |g Vol. 80, No. 3 (1983), p. 870-873  |q 80:3<870-873  |w (DE-601)JST069399220  |x 0027-8424 
856 4 1 |u https://www.jstor.org/stable/13773  |3 Volltext 
912 |a GBV_JSTOR 
951 |a AR 
952 |d 80  |j 1983  |e 3  |h 870-873 

Similar Items

Cannot find similar records

Library Services

Search Options

Quick links

Orientation